Vimarsana
Biggest News Aggregation in the World

Page 8 - Human Frontier Science Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Frontier Science Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Frontier Science Program Today - Breaking & Trending Today

Manipulating microglia behavior with light - Vimarsana News

Manipulating microglia behavior with light

An international research team, comprising scientists from DZNE, University Hospital Bonn, the Netherlands, and the US has been awarded a US$ 1.3 million grant by the "Human Frontier Science Program" to investigate brain immune cells and manipulate them via light irradiation.

Researchers study brain immune cells and used laser irradiation to alter them - Vimarsana News

Researchers study brain immune cells and used laser irradiation to alter them

A multinational study team led by experts from DZNE, University Hospital Bonn, and the Netherlands studied brain immune cells and used laser irradiation to alter them

Researchers study brain immune cells and used laser irradiation to alter them - Vimarsana News

Researchers study brain immune cells and used laser irradiation to alter them

A multinational study team led by experts from DZNE, University Hospital Bonn, and the Netherlands studied brain immune cells and used laser irradiation to alte

UC-led research team receives NIH grant to study the role of an enzyme in lysosome function - Vimarsana News

UC-led research team receives NIH grant to study the role of an enzyme in lysosome function

Once thought of as having one simple job within cells, researchers continue to learn more about the importance of organelles called lysosomes.

Two Ludwig cancer research studies reveal ess - Vimarsana News

Two Ludwig cancer research studies reveal ess

Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.